Is Sermorelin Legal in Maryland? How to Access It Legally
Key numbers
- 0.05 mgStrength of Geref's 0.05 mg ampule, one of its two approved products, which was for pituitary testingSource: federalregister.gov, as cited Nov 7, 2026
- 30 micrograms per kgResearch dose in children; published research dose, not a recommended doseSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 14 daysDuration of the research dosing in older men; not a recommended doseSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
See the public record for Sermorelin
At a glance
- FDA-approved sermorelin / None; Geref's approvals ended June 18, 2009 [1]
- Geref's approved uses / Pituitary diagnostic test; pediatric growth hormone deficiency [1]
- Ever approved for adults or anti-aging / No [1]
- Sermorelin products in the US today / Compounded, not FDA-approved [2]
- FDA significant-safety-risk list / Sermorelin not listed [3]
- Nomination status for outsourcing facilities / Category 1, under evaluation [4]
- State-licensed pharmacy bulks list / No category listing [5]
- Athletes / WADA bans it at all times [6]
Is sermorelin legal to buy in the United States?
Sermorelin is a 29-amino-acid analogue of growth hormone-releasing hormone. It prompts the pituitary to release the body's own growth hormone, and it is not growth hormone itself [7].
Geref, made by EMD Serono, was the only approved sermorelin, and it existed under two applications: NDA 019863 for the 0.05 mg ampule and NDA 020443 for the 0.5 mg and 1 mg vials [1]. The manufacturer discontinued both products in 2008 and asked FDA to withdraw the applications, which FDA did effective June 18, 2009 [1]. Drugs@FDA lists both as discontinued [1][8].
Sermorelin products in the US today are compounded, not FDA-approved [2]. FDA states that it does not verify the safety, effectiveness or quality of a compounded drug before it is marketed [2][9].
What was Geref approved to do?
The 0.05 mg ampule was approved for evaluating the pituitary's ability to secrete growth hormone; the vials were approved for treating idiopathic growth hormone deficiency in children with growth failure [1]. Adults, anti-aging, weight loss and athletic performance were never approved uses [1].
In March 2013 FDA determined that Geref was not withdrawn from sale for reasons of safety or effectiveness [1][8].
Where sermorelin sits on FDA's compounding lists
Sermorelin does not appear on FDA's list of bulk substances that may present significant safety risks, in the version dated April 22, 2026 [3]. On the list of nominated bulk substances for outsourcing facilities, updated March 21, 2025, sermorelin acetate is in category 1, under evaluation, and carries the list's marker for substances that are components of FDA-approved drugs [4]. On FDA's list for state-licensed pharmacies and physicians, updated May 14, 2026, it appears in no category [5], and it is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy [10].
None of that is an FDA approval.
What about Maryland specifically?
This page does not establish a Maryland-specific rule for sermorelin. FDA says state boards of pharmacy generally have primary day-to-day oversight of state-licensed pharmacies that are not registered with FDA as outsourcing facilities [9]. Federally, there is no approved sermorelin product and no current approved dose [1]. The doses used in published research were 30 micrograms per kg once daily subcutaneously at bedtime in children [11] and 0.5 mg or 1 mg subcutaneously twice daily for 14 days in older men [12]. Neither is a recommended dose.
Questions worth asking
Does sermorelin's sport status matter?
WADA's 2026 Prohibited List names sermorelin in S2.2.4, growth hormone releasing factors, prohibited at all times, in and out of competition, as a non-Specified substance [6]. The 2027 list, in force January 1, 2027, names it as well [13].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Frequently asked questions
Is sermorelin legal in Maryland?
Is sermorelin FDA-approved?
Why did Geref leave the market?
Was sermorelin ever approved for anti-aging or weight loss?
Can athletes use sermorelin?
References
Show all 13 referencesHide references
- Federal Register :: Request Access.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
- U.S. Food and Drug Administration.
- Compounding and the FDA: Questions and Answers | FDA.
- Official web page.
- Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
- Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
- World Anti-Doping Agency.